These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18135420)

  • 1. Electrographic study of the convulsant action of intravenously administered acetylcholine.
    AJMONE-MARSAN C; FUORTES MG
    Electroencephalogr Clin Neurophysiol; 1949 Aug; 1(3):283-90. PubMed ID: 18135420
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizure discharges effected by intravenously administered convulsant drugs; EEG and DC changes in cerebrum and cerebellum of the rabbit.
    VANASUPA P; GOLDRING S; O'LEARY JL
    Electroencephalogr Clin Neurophysiol; 1959 Feb; 11(1):93-106. PubMed ID: 13630236
    [No Abstract]   [Full Text] [Related]  

  • 3. [Isoniazid concentration in the cerebrospinal fluid of the ape and dog after intravenous administration, and relation to its convulsant effect].
    PERITI P; BUFFONI NARDINI F
    Boll Soc Ital Biol Sper; 1953 Mar; 29(3):350-2. PubMed ID: 13081856
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of convulsant and narcotic drugs on acetylcholine synthesis.
    McLENNAN H; ELLIOTT KA
    J Pharmacol Exp Ther; 1951 Sep; 103(1):35-43. PubMed ID: 14881066
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of the convulsant action of pregnenolone sulfate.
    Williamson J; Mtchedlishvili Z; Kapur J
    Neuropharmacology; 2004 May; 46(6):856-64. PubMed ID: 15033345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Convulsant threshold in children of epileptic patients; electroencephalographic studies].
    HARVALD B
    Nord Med; 1951 May; 45(19):726-7. PubMed ID: 14853192
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of pro-convulsant risk in the rat: spontaneous and provoked convulsions.
    Esneault E; Peyon G; Froger-Colléaux C; Castagné V
    J Pharmacol Toxicol Methods; 2015; 72():59-66. PubMed ID: 25307194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The threshold for limbic seizures in rats is decreased by intranigral morphine.
    Turski WA; Bortolotto ZA; Ikonomidou-Turski C; Moraes Mello LE; Cavalheiro EA; Turski L
    NIDA Res Monogr; 1986; 75():547-50. PubMed ID: 3123975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convulsant action of naloxone in the rat amygdala.
    Ikonomidou-Turski C; Turski WA; Bortolotto ZA; Turski L; Cavalheiro EA
    NIDA Res Monogr; 1986; 75():535-8. PubMed ID: 3123974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between hippocampal acetylcholine release and cholinergic convulsant sensitivity in withdrawal seizure-prone and withdrawal seizure-resistant selected mouse lines.
    Mark GP; Finn DA
    Alcohol Clin Exp Res; 2002 Aug; 26(8):1141-52. PubMed ID: 12198388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study of the toxic convulsant properties of commercial preparations of essences of sage and hyssop (author's transl)].
    Millet Y; Tognetti P; Lavaire-Perlovisi M; Steinmetz MD; Arditti J; Jouglard J
    Rev Electroencephalogr Neurophysiol Clin; 1979; 9(1):12-8. PubMed ID: 493616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of sensory seizures: brain-stem neuronal response changes and convulsant drugs.
    Faingold CL; Hoffmann WE; Caspary DM
    Fed Proc; 1985 May; 44(8):2436-41. PubMed ID: 3886431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convulsant action of antihistamines in monkeys.
    CHUSID JG; KOPELOFF LM; KOPELOFF N
    J Appl Physiol; 1956 Sep; 9(2):271-4. PubMed ID: 13376441
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of anesthetics and convulsants on brain acetylcholine content.
    TOBIAS JM; LIPTON MA; LEPINAT AA
    Proc Soc Exp Biol Med; 1946 Jan; 61():51-4. PubMed ID: 21013794
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavioral and EEG signs of the convulsive action of kynurenine and quinolinic acid in cats].
    Dutov AA; Tolpyshev BA
    Farmakol Toksikol; 1987; 50(3):33-6. PubMed ID: 2956122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal mechanisms involved in the convulsant action of 5,7-diphenyl-1,3-diazadamantan-6-ol (1757 I.S.).
    LONGO VG
    J Pharmacol Exp Ther; 1961 May; 132():240-4. PubMed ID: 13763384
    [No Abstract]   [Full Text] [Related]  

  • 17. The availability of hexafluorodiethyl ether by intravenous injection as a convulsant in psychiatric treatment.
    KRANTZ JC; MANCHEY LL; TRUITT EB; LING AS; KURLAND AA
    J Nerv Ment Dis; 1959 Jul; 129():92-4. PubMed ID: 14411701
    [No Abstract]   [Full Text] [Related]  

  • 18. [Investigations on the anti-convulsant properties of apocaffeine].
    MERCIER J; LESPAGNOL C
    C R Seances Soc Biol Fil; 1952 May; 146(9-10):744-7. PubMed ID: 12998237
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the convulsant properties of 5,7-diphenyl-1,3-diazadamantan-6-ol (IS-1757)].
    LONGO VG; SILVESTRINI B; BOVET D
    Rend Ist Sup Sanit; 1960; 23():1095-109. PubMed ID: 13763382
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characterization of an experimental model of monosodium- glutamate-induced convulsions in the amphibian Bufo spp].
    Alfaro F; Blas O; Gutiérrez-Padilla R; Feria-Velasco A
    Arch Invest Med (Mex); 1990; 21(4):405-11. PubMed ID: 1669233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.